ロード中...
Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4
IMPORTANCE: Age-related cataract is a leading cause of visual impairment in the United States. The prevalence of age-related cataract is increasing, with an estimated 30.1 million Americans likely to be affected by 2020. OBJECTIVE: To determine whether daily oral supplementation with lutein/zeaxanth...
保存先:
| 出版年: | JAMA Ophthalmol |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774801/ https://ncbi.nlm.nih.gov/pubmed/23645227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2013.4412 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|